Skip to main content
Indo Count Industries Ltd logo

Indo Count Industries Ltd — Investor Relations & Filings

Ticker · ICIL ISIN · INE483B01026 LEI · 335800K2IZ3N44GS9379 BSE.NS Manufacturing
Filings indexed 2,070 across all filing types
Latest filing 2021-09-28 Regulatory Filings
Country IN India
Listing BSE.NS ICIL

About Indo Count Industries Ltd

https://www.indocount.com

Indo Count Industries Ltd is a specialized home textile manufacturer focused on the production and export of premium bed linen. The company’s product portfolio includes a comprehensive range of bedding solutions, such as bed sheets, duvet covers, pillowcases, bed skirts, and shams, catering to both basic and fashion bedding segments. Operating with vertically integrated manufacturing facilities, the firm manages processes from spinning and weaving to processing and finishing. Indo Count serves a global clientele comprising major international retailers, department stores, and hospitality brands across North America, Europe, and other key markets. The company emphasizes innovation through specialized finishes and high-thread-count fabrics, maintaining a commitment to quality and sustainable manufacturing practices to meet evolving consumer demands in the global home decor sector.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about an NCLT order directing the company to convene a meeting of equity shareholders for approval of a scheme of amalgamation. The document is a formal notification to stock exchanges about a regulatory event and meeting arrangement, not the actual scheme document or detailed report. The length is short (2962 characters) and it serves as an announcement rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2021-09-28 English
Loss of Share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal communication addressed to stock exchanges regarding the issuance of a duplicate share certificate to a shareholder. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3), which pertains to share certificate issuance. The content includes details of the shareholder, certificate numbers, and shares involved. There is no financial data, management discussion, or report attached. The document is an announcement of a corporate action related to share certificates, specifically the issuance of duplicate certificates, which aligns with the category of Share Issue/Capital Change (SHA). The document length is short and focused solely on this notification, not a report or financial statement.
2021-09-24 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company has issued Duplicate Share Certificate ....
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the issuance of a duplicate share certificate under SEBI regulations. It details the shareholder's name, certificate numbers, and shares involved. There is no financial data, earnings information, or management discussion. The document is a regulatory announcement about share certificate duplication, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like share issue or capital change (SHA) since it is about duplicate certificates, not new shares or capital changes.
2021-09-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification to stock exchanges about the schedule of analyst meetings, referencing SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It mentions that the Q1 FY22 Investor Presentation has been submitted to the stock exchange, but the document itself is an intimation or announcement of the meeting schedule and submission, not the presentation or report itself. The document length is short (1487 characters), and it serves as a regulatory announcement rather than containing financial data or the presentation content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2021-09-23 English
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of analyst meetings and mentions that the Q1 FY22 Investor Presentation has been submitted. It is an announcement of an upcoming investor presentation meeting rather than the presentation itself or a detailed financial report. The document length is only 1487 characters, indicating it is a brief announcement. According to the rules, such announcements about meetings and presentations fall under Investor Presentation (IP) if the presentation itself is included, but here it is only an intimation of the schedule and submission of the presentation to the exchange, not the presentation content itself. Therefore, it is best classified as Regulatory Filings (RNS) because it is a regulatory announcement under SEBI regulations about analyst meetings and submission of presentation, but does not contain the presentation or detailed financial data itself.
2021-09-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst meetings and the submission of an investor presentation for Q1 FY22. It references SEBI Listing Obligations and Disclosure Requirements, indicating a regulatory compliance announcement. The document is short (3032 characters) and does not contain any financial statements or detailed financial data. It primarily serves as an announcement of an upcoming investor presentation and the schedule of analyst meetings. Therefore, it is not the investor presentation itself but an announcement related to it. According to the classification rules, such announcements fall under Regulatory Filings (RNS) as they do not contain the full report or detailed financial data but are regulatory disclosures about events or filings.
2021-09-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.